The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Karabelas Argeris N since year 2005.
The trader's CIK number is 1191229.
At the time of this reporting, Karabelas Argeris N is the Director of Biovail Corp International .
(stock ticker symbol BVF).
See this page for all insider trading activities at Biovail Corp International .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2016-08-11 | VRX | Biovail Corp International | Buy | 4,000 | 24.65 | 98,600 |
| 2015-02-23 | ITEK | Inotek Pharmaceuticals Corp | Buy | 603,832 | 6.00 | 3,622,992 |
| 2010-03-12 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 200,000 | 11.80 | 2,360,000 |
| 2009-12-14 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 130,000 | 11.14 | 1,448,200 |
| 2009-12-15 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 98,924 | 11.03 | 1,091,131 |
| 2009-12-09 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 107,200 | 11.57 | 1,240,304 |
| 2009-12-08 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 26,376 | 11.30 | 298,048 |
| 2009-12-04 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 100,000 | 11.70 | 1,170,000 |
| 2009-12-07 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 100,000 | 11.57 | 1,157,000 |
| 2009-10-13 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 237,500 | 12.65 | 3,004,375 |
| 2009-07-15 | BDSI | Biodelivery Sciences International Inc | Sale | 27,770 | 6.00 | 166,675 |
| 2009-07-16 | BDSI | Biodelivery Sciences International Inc | Sale | 131,374 | 6.89 | 905,298 |
| 2009-07-07 | BDSI | Biodelivery Sciences International Inc | Sale | 13,158 | 6.12 | 80,579 |
| 2009-07-08 | BDSI | Biodelivery Sciences International Inc | Sale | 261 | 6.25 | 1,631 |
| 2009-07-02 | BDSI | Biodelivery Sciences International Inc | Sale | 6,511 | 6.45 | 42,002 |
| 2009-07-06 | BDSI | Biodelivery Sciences International Inc | Sale | 70,000 | 6.18 | 432,530 |
| 2009-07-01 | BDSI | Biodelivery Sciences International Inc | Sale | 50,000 | 6.75 | 337,750 |
| 2009-06-30 | BDSI | Biodelivery Sciences International Inc | Sale | 32,640 | 6.68 | 217,904 |
| 2009-06-26 | BDSI | Biodelivery Sciences International Inc | Sale | 477,509 | 6.86 | 3,273,324 |
| 2009-06-29 | BDSI | Biodelivery Sciences International Inc | Sale | 215,791 | 6.88 | 1,484,210 |
| 2009-06-24 | BDSI | Biodelivery Sciences International Inc | Sale | 12,559 | 6.48 | 81,419 |
| 2009-06-25 | BDSI | Biodelivery Sciences International Inc | Sale | 38,965 | 6.51 | 253,506 |
| 2009-06-22 | BDSI | Biodelivery Sciences International Inc | Sale | 11,657 | 6.56 | 76,434 |
| 2009-06-23 | BDSI | Biodelivery Sciences International Inc | Sale | 32,800 | 6.30 | 206,771 |
| 2009-06-19 | BDSI | Biodelivery Sciences International Inc | Sale | 110,614 | 6.54 | 723,526 |
| 2009-06-18 | BDSI | Biodelivery Sciences International Inc | Sale | 63,391 | 6.50 | 412,231 |
| 2009-06-17 | BDSI | Biodelivery Sciences International Inc | Sale | 100,000 | 6.40 | 640,200 |
| 2007-02-23 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 384,130 | 26.02 | 9,993,526 |
| 2007-02-22 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 72,600 | 26.82 | 1,947,277 |
| 2007-02-20 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 200,000 | 27.37 | 5,474,200 |
| 2007-02-21 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 237,000 | 26.74 | 6,337,380 |
| 2006-12-12 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 424,150 | 25.18 | 10,680,097 |
| 2006-12-11 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 326,325 | 26.40 | 8,614,980 |
| 2006-11-27 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 300,000 | 14.18 | 4,254,000 |
| 2006-11-22 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 300,000 | 14.12 | 4,236,000 |
| 2006-11-21 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 50,000 | 14.55 | 727,500 |
| 2006-11-17 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 270,000 | 14.25 | 3,847,500 |
| 2006-11-20 | VNDA | Vanda Pharmaceuticals Inc. | Sale | 50,000 | 15.29 | 764,500 |
| 2006-11-10 | HGSI | Human Genome Sciences Inc | Buy | 12,500 | 12.15 | 151,875 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Karabelas Argeris N (Director of Biovail Corp International at the time of this reporting) see the Securities and Exchange Commission (SEC) website.